Occam Places Amgen CMO on Board of Moonwalk
In June 2025, Occam Global placed Paul Burton, MD, PhD, on the Board of Moonwalk Biosciences.
Burton became Amgen’s CMO in June 2023. Prior to joining Amgen, he served as the CMO of Moderna Therapeutics from 2021 to 2023 and spent 16 years at J&J, where his most recent role was Chief Global Medical Affairs Officer.
Burton has over 20 years of experience in the biopharmaceutical industry, covering all phases of drug discovery and development, including both small and large molecules, as well as mRNA therapeutics. He has also worked in various therapeutic areas, such as oncology, cardiovascular and metabolic diseases, and infectious diseases.
He earned his BSc in Physiology from King’s College London, his MD from the University of London, and his PhD in Philosophy from Imperial College London.
Read more about Occam's biotech board recruiting:
Bob D. Brown for Mammoth Biosiences
Namandje Bumpus, PhD and Elaine Sun for Recursion
Stephen M. Hahn, MD for Faeth Therapeutics
Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.